Information for Former Mobileye Shareholders

In March 2017, Intel and Mobileye announced that they had entered into a definitive agreement pursuant to which Intel would acquire Mobileye.  Under the terms of that agreement, a subsidiary of Intel commenced a tender offer to acquire all the outstanding shares of Mobileye for $63.54 per share in cash.  Intel acquired approximately 97.3% of Mobileye’s outstanding shares upon the expiration of that tender offer in August 2017.

In March 2018, the Enterprise Chamber of the Amsterdam Court of Appeals rendered a final judgment in a statutory compulsory acquisition proceeding covering all Mobileye shares that remained outstanding after the completion of the tender offer. Pursuant to this order, all remaining outstanding shares of Mobileye were transferred by operation of law to Intel on April 26, 2018, and Intel deposited funds for such shares with the consignment office of the Dutch Ministry of Finance pursuant to Dutch law.

Investors whose shares were transferred by operation of law should contact the broker through which they held Mobileye shares for instructions and information on how to obtain payment from the consignment office of the Dutch Ministry of Finance.  Investors who have questions about these payment procedures that their broker is unable to answer may also contact D.F. King, who was the information agent for the acquisition, at 1-800-966-9021 (calls within the U.S.) or 212-771-1130 (calls from outside of the U.S.), or by sending an e-mail to mobileye@dfking.com.

Bankers or brokers may direct questions and requests for assistance to the Dutch consignment office at consignatiekas@minfin.nl. Please note that the Dutch consignment office will not answer questions from former Mobileye shareholders directly.  As the remaining payment procedures are now under the administration of the Dutch consignment office, please also note that Intel is not able to provide updates about the status or timing of the Dutch consignment office’s review of individual payment claims.